Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit
David Wright et. al. The American Journal of Obstetrics & Gynecology
Articles and resources
Aspirin versus Placebo in Pregnancies at high Risk for Preterm Preeclampsia
Daniel L. Rolnik et. al. The New England Journal of Medicine
Multiplex Real-time PCR Newborn Screening Assay to Simultaneously Identify Spinal Muscular Atrophy and Severe Combined Immunodeficiency
Professor Mei Baker discusses Identifying Spinal Muscular Atrophy and Severe Combined Immunodeficiency using Real-time PCR newborn screening
PlGF and assessment of placental function in the first and third trimesters of pregnancy
Professor Jon Hyett, Head of High-Risk Obstetrics and a Senior Staff Specialist in Obstetrics, and Maternal and Fetal Medicine Royal Prince Alfred Hospital, Sydney, Australia
First SMA baby identified with our screening solutions in Australia
A newborn baby has been identified as having SMA (spinal muscular atrophy) in Westmead Children’s Hospital in Australia, using a 4-plex SMA, SCID and XLA laboratory developed test
First trimester prediction and prevention of pre-eclampsia
Kypros Nicolaides, Professor at King’s College Hospital, London (UK) and founder of Fetal Medicine Foundation (FMF) presents the latest development on predicition and prevention of preterm pre-eclampsia.
First Trimester Prediction and Prevention of Pre-term Pre-eclampsia Webinar Transcript
Products may not be licensed in accordance with the laws in all countries, such as the United States, Canada. Please check with your local representative for availability.
Revvity does not endorse or make recommendations with respect to research, medication, or treatments. All information presented is for informational purposes only and is not intended as medical advice. For country specific recommendations please consult your local health care professionals.
